HomeNRXBF • OTCMKTS
add
Nurexone Biologic Inc
Previous close
$0.52
Day range
$0.48 - $0.49
Year range
$0.38 - $0.80
Market cap
57.93M CAD
Avg Volume
10.40K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change | 
|---|---|---|
| Revenue | — | — | 
| Operating expense | 1.82M | 38.03% | 
| Net income | -1.85M | -39.32% | 
| Net profit margin | — | — | 
| Earnings per share | -0.02 | — | 
| EBITDA | -1.78M | -36.19% | 
| Effective tax rate | — | — | 
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change | 
|---|---|---|
| Cash and short-term investments | 1.23M | -48.51% | 
| Total assets | 2.86M | -13.00% | 
| Total liabilities | 1.33M | 85.77% | 
| Total equity | 1.53M | — | 
| Shares outstanding | 81.43M | — | 
| Price to book | 25.96 | — | 
| Return on assets | -182.05% | — | 
| Return on capital | -306.73% | — | 
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change | 
|---|---|---|
| Net income | -1.85M | -39.32% | 
| Cash from operations | -1.07M | -22.64% | 
| Cash from investing | -2.00K | 97.18% | 
| Cash from financing | 1.59M | 3,513.64% | 
| Net change in cash | 640.00K | 173.56% | 
| Free cash flow | -459.38K | 17.55% | 
About
Founded
2011
Website
Employees
9
